HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S B Seredenin Selected Research

ethyl phenylacetyl-Pro-Gly

9/2020Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.
1/2016Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept.
1/2013Efficiency of noopept in streptozotocin-induced diabetes in rats.
12/2010[On the mechanism of noopept action: decrease in activity of stress-induced kinases and increase in expression of neutrophines].
9/2008Noopept stimulates the expression of NGF and BDNF in rat hippocampus.
9/2002[The original novel nootropic and neuroprotective agent noopept].
3/2002[Anti-inflammatory properties of noopept (dipeptide nootropic agent GVS-111)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S B Seredenin Research Topics

Disease

10Ischemia
09/2019 - 03/2006
6Brain Ischemia (Cerebral Ischemia)
07/2019 - 09/2002
6Body Weight (Weight, Body)
09/2018 - 10/2010
5Infarction (Infarctions)
09/2018 - 02/2011
5Ischemic Stroke
12/2017 - 07/2006
5Hematoma
03/2015 - 11/2005
5Alzheimer Disease (Alzheimer's Disease)
01/2015 - 07/2007
5Chromosome Aberrations (Chromosome Abnormalities)
01/2006 - 03/2000
4Weight Loss (Weight Reduction)
10/2020 - 01/2013
4Type 2 Diabetes Mellitus (MODY)
10/2020 - 04/2017
4Hypoxia (Hypoxemia)
09/2020 - 01/2012
4Stroke (Strokes)
07/2019 - 02/2011
4Hyperglycemia
01/2019 - 04/2017
4Pheochromocytoma
01/2014 - 10/2007
4Hemorrhagic Stroke
03/2013 - 01/2009
4Pain (Aches)
01/2013 - 03/2005
3Hyperalgesia
11/2020 - 01/2015
3Diabetes Mellitus
04/2018 - 11/2014
3Neuroblastoma
01/2014 - 01/2012
3Inflammation (Inflammations)
11/2011 - 03/2002
3Cognitive Dysfunction
05/2011 - 07/2007
2Shock
06/2020 - 03/2005
2Brain Injuries (Brain Injury)
07/2019 - 01/2012
2Anxiety Disorders (Anxiety Disorder)
01/2019 - 01/2008
2Hyperphagia (Overeating)
01/2019 - 09/2018
2Polydipsia
01/2019 - 09/2018
2Parkinson Disease (Parkinson's Disease)
01/2016 - 10/2007
2Heart Arrest (Cardiac Arrest)
08/2015 - 04/2015
2Hemorrhage
03/2015 - 11/2014
2Hypercapnia
02/2015 - 01/2012
2Edema (Dropsy)
11/2014 - 03/2011
2Catalepsy
10/2011 - 01/2009
2Parkinsonian Disorders (Parkinsonism)
10/2011 - 02/2008
1Mental Disorders (Mental Disorder)
01/2021
1Opioid-Related Disorders (Opiate Addiction)
11/2020
1Autism Spectrum Disorder
12/2019
1Coronary Occlusion
09/2018
1Heart Failure
09/2018
1Alcoholism (Alcohol Abuse)
12/2017
1Dementia (Dementias)
04/2017
1Stupor
01/2016
1Ataxia (Dyssynergia)
01/2016

Drug/Important Bio-Agent (IBA)

222- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazoleIBA
10/2020 - 03/2000
16DipeptidesIBA
06/2020 - 03/2002
14Anti-Anxiety Agents (Anxiolytics)IBA
01/2019 - 11/2005
11Nerve Growth Factor (NGF)IBA
07/2019 - 02/2008
10Streptozocin (Streptozotocin)FDA Link
10/2020 - 01/2013
8Neuroprotective AgentsIBA
07/2013 - 09/2002
7Nerve Growth Factors (Neurotrophins)IBA
01/2021 - 09/2008
7ethyl phenylacetyl-Pro-GlyIBA
09/2020 - 03/2002
7Pharmaceutical PreparationsIBA
02/2014 - 03/2002
5Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 12/2010
3bis- (N- monosuccinyl- l- seryl- l- lysine)hexamethylenediamideIBA
11/2020 - 07/2013
3DNA (Deoxyribonucleic Acid)IBA
09/2020 - 10/2015
3Lysine (L-Lysine)FDA Link
07/2019 - 01/2012
3Hypoglycemic Agents (Hypoglycemics)IBA
09/2018 - 01/2013
3Nootropic Agents (Nootropics)IBA
07/2015 - 07/2007
3SmokeIBA
03/2015 - 05/2011
3N-(2-adamantyl)-N-p-bromophenylamineIBA
11/2011 - 05/2009
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
03/2011 - 10/2007
3Analgesics (Analgesic Drugs)IBA
01/2008 - 03/2005
3dioxidineIBA
11/2001 - 03/2000
2Isoproterenol (Isoprenaline)FDA LinkGeneric
09/2019 - 10/2013
2GB-115IBA
01/2019 - 03/2011
2Metformin (Glucophage)FDA LinkGeneric
01/2019 - 09/2018
2Proteins (Proteins, Gene)FDA Link
09/2018 - 03/2008
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2017 - 01/2016
2Ethanol (Ethyl Alcohol)IBA
01/2016 - 08/2014
2N-(2-adamantyl)hexamethylenimineIBA
01/2016 - 03/2008
2SoilIBA
03/2015 - 03/2015
2cyclo(prolylglycyl)IBA
02/2015 - 01/2012
2NeurotoxinsIBA
07/2013 - 03/2011
2Haloperidol (Haldol)FDA LinkGeneric
10/2011 - 01/2009
2CarrageenanIBA
03/2011 - 03/2002
2AntioxidantsIBA
10/2009 - 07/2007
2Antipsychotic Agents (Antipsychotics)IBA
09/2009 - 01/2009
2Acetic Acid (Vinegar)FDA LinkGeneric
01/2008 - 09/2007
2Formaldehyde (Formol)FDA Link
01/2008 - 09/2007
2Peptides (Polypeptides)IBA
01/2008 - 03/2005
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
10/2020
1Therapeutic UsesIBA
07/2019
1TabletsIBA
01/2019
1Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
01/2019
1Vasopressins (Vasopressin)IBA
09/2018
1Biomarkers (Surrogate Marker)IBA
09/2018
1GlucocorticoidsIBA
09/2018
1Brain Natriuretic Peptide (Natrecor)FDA Link
09/2018
1RNA (Ribonucleic Acid)IBA
09/2018
1AngiotensinsIBA
09/2018
1AdamantaneIBA
12/2017
1hemantaneIBA
12/2017
1emoxypine succinateIBA
12/2017
1Amantadine (Aman)FDA LinkGeneric
01/2016
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2016
1Betaine (C.B.B.)FDA Link
10/2015

Therapy/Procedure

8Intraperitoneal Injections
09/2019 - 02/2008
7Therapeutics
01/2021 - 10/2007
2Aftercare (After-Treatment)
09/2018 - 07/2013
2Resuscitation
08/2015 - 04/2015
2Oral Administration
10/2011 - 09/2009